The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...

A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Only 200,000, or 3%, are diagnosed with Alzheimer's before age 65. Such an early onset means the disease is more likely to ...

TORONTO – Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease.   Lecanemab is the first ...

Cognition Therapeutics, Inc. ( ($CGTX) ) has released its Q3 earnings. Here is a breakdown of the information Cognition Therapeutics, Inc.

November is Alzheimer’s Awareness Month, a time to spotlight the growing impact of the disease across the United States and ...